Almirall, S.A. (BME:ALM)
Spain · Delayed Price · Currency is EUR 13.22
+0.04 (0.30%)
At close: Jan 16, 2026
Almirall Market Cap
Almirall has a market cap or net worth of €2.84 billion as of January 16, 2026. Its market cap has increased by 61.72% in one year.
Market Cap
2.84B
Enterprise Value
2.80B
Revenue
1.09B
Ranking
n/a
PE Ratio
67.53
Stock Price
€13.22
Market Cap Chart
Since June 20, 2007, Almirall's market cap has increased from 2.37B to 2.84B, an increase of 19.73%. That is a compound annual growth rate of 0.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 2.84B | 2.96% |
| Dec 31, 2025 | 2.76B | 56.88% |
| Dec 31, 2024 | 1.76B | -0.35% |
| Dec 29, 2023 | 1.76B | 7.51% |
| Dec 30, 2022 | 1.64B | -19.23% |
| Dec 30, 2021 | 2.03B | 4.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.61B |
| Laboratorios Farmaceuticos Rovi | 3.53B |
| Faes Farma | 1.62B |
| Pharma Mar | 1.38B |
| Clínica Baviera | 829.43M |
| Oryzon Genomics | 257.85M |
| Atrys Health | 232.18M |
| Prim, S.A. | 225.46M |